88Q.DE XETRA
4basebio PLC
1W: -1.4%
1M: -9.4%
3M: -25.1%
YTD: -21.6%
1Y: -62.6%
3Y: -31.8%
€5.30 ($6.16)
+0.32 (+6.43%)
Weekly Expected Move ±4.7%
€4
€4
€5
€5
€5
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Smart Money Score
No convergence signal
Key Statistics
Market Cap€77.1M ($89.7M)
52W Range4.64-13.2
Volume1,080
Avg Volume289
Beta0.87
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOAmy Jo Walker
Employees101
SectorHealthcare
IndustryBiotechnology
IPO Date2021-11-23
Website4basebio.com
25 Norman Way
Cambridge
GB
Cambridge
GB
+44 1223 967943
About 4basebio PLC
4basebio Plc is a biotechnology company, which engages in the business of developing advanced therapy medicinal products through synthetic DNA products and non-viral, cell targeting nucleic acid delivery platforms. The firm is involved in manufacturing and supplying high quality synthetic DNA products for research, therapeutic, and pharmacological use; and developing target specific non-viral vectors for the efficient delivery of payloads in patients. The company was founded on December 22, 2020 and is headquartered in Cambridge, the United Kingdom.
Latest News
No recent news
Recent Insider Trades
No insider trades found